These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 15561320)
1. Clinical and pharmacological significance of alpha2-adrenoceptor polymorphisms in cardiovascular diseases. Flordellis C; Manolis A; Scheinin M; Paris H Int J Cardiol; 2004 Dec; 97(3):367-72. PubMed ID: 15561320 [TBL] [Abstract][Full Text] [Related]
2. Expression and function of alpha-adrenoceptors in zebrafish: drug effects, mRNA and receptor distributions. Ruuskanen JO; Peitsaro N; Kaslin JV; Panula P; Scheinin M J Neurochem; 2005 Sep; 94(6):1559-69. PubMed ID: 16000146 [TBL] [Abstract][Full Text] [Related]
3. Alpha2-adrenoceptor subtypes--unexpected functions for receptors and ligands derived from gene-targeted mouse models. Knaus AE; Muthig V; Schickinger S; Moura E; Beetz N; Gilsbach R; Hein L Neurochem Int; 2007 Oct; 51(5):277-81. PubMed ID: 17664025 [TBL] [Abstract][Full Text] [Related]
4. Enteric alpha-2 adrenoceptors: pathophysiological implications in functional and inflammatory bowel disorders. Blandizzi C Neurochem Int; 2007 Oct; 51(5):282-8. PubMed ID: 17618014 [TBL] [Abstract][Full Text] [Related]
5. Ligand-induced alpha2-adrenoceptor endocytosis: relationship to Gi protein activation. Olli-Lähdesmäki T; Tiger M; Vainio M; Scheinin M; Kallio J Biochem Biophys Res Commun; 2004 Aug; 321(1):226-33. PubMed ID: 15358239 [TBL] [Abstract][Full Text] [Related]
6. Genetic dissection of alpha2-adrenoceptor functions in adrenergic versus nonadrenergic cells. Gilsbach R; Röser C; Beetz N; Brede M; Hadamek K; Haubold M; Leemhuis J; Philipp M; Schneider J; Urbanski M; Szabo B; Weinshenker D; Hein L Mol Pharmacol; 2009 May; 75(5):1160-70. PubMed ID: 19251826 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo profiling of fadolmidine, a novel potent alpha(2)-adrenoceptor agonist with local mode of action. Lehtimäki J; Leino T; Koivisto A; Viitamaa T; Lehtimäki T; Haapalinna A; Kuokkanen K; Virtanen R Eur J Pharmacol; 2008 Dec; 599(1-3):65-71. PubMed ID: 18930723 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterisation of a structurally novel α2C-adrenoceptor antagonist ORM-10921 and its effects in neuropsychiatric models. Sallinen J; Holappa J; Koivisto A; Kuokkanen K; Chapman H; Lehtimäki J; Piepponen P; Mijatovic J; Tanila H; Virtanen R; Sirviö J; Haapalinna A Basic Clin Pharmacol Toxicol; 2013 Oct; 113(4):239-49. PubMed ID: 23718812 [TBL] [Abstract][Full Text] [Related]
14. Discriminative stimulus properties of the selective and highly potent alpha2-adrenoceptor agonist, S18616, in rats: mediation by the alpha2A subtype, and blockade by the atypical antidepressants, mirtazapine and mianserin. Dekeyne A; Millan MJ Neuropharmacology; 2006 Sep; 51(4):718-26. PubMed ID: 16814817 [TBL] [Abstract][Full Text] [Related]
15. Yohimbine dimers exhibiting selectivity for the human alpha 2C-adrenoceptor subtype. Lalchandani SG; Lei L; Zheng W; Suni MM; Moore BM; Liggett SB; Miller DD; Feller DR J Pharmacol Exp Ther; 2002 Dec; 303(3):979-84. PubMed ID: 12438517 [TBL] [Abstract][Full Text] [Related]
16. α2C-adrenoceptor modulators: a patent review. Quaglia W; Del Bello F; Giannella M; Piergentili A; Pigini M Expert Opin Ther Pat; 2011 Apr; 21(4):455-81. PubMed ID: 21413828 [TBL] [Abstract][Full Text] [Related]
17. Alpha2-adrenergic receptors activate cyclic AMP-response element-binding protein through arachidonic acid metabolism and protein kinase A in a subtype-specific manner. Karkoulias G; Mastrogianni O; Papathanasopoulos P; Paris H; Flordellis C J Neurochem; 2007 Nov; 103(3):882-95. PubMed ID: 17680988 [TBL] [Abstract][Full Text] [Related]
18. Beta-1 and beta-2 adrenoceptor polymorphisms: functional importance, impact on cardiovascular diseases and drug responses. Brodde OE Pharmacol Ther; 2008 Jan; 117(1):1-29. PubMed ID: 17916379 [TBL] [Abstract][Full Text] [Related]
19. Association between common genetic variants of α2A-, α2B-, and α2C-adrenergic receptors and ischemic stroke. Oh SH; Min KT; Jeon YJ; Kim MH; Kim OJ; Shin BS; Oh D; Kim NK Clin Neurol Neurosurg; 2013 Jan; 115(1):26-31. PubMed ID: 22560155 [TBL] [Abstract][Full Text] [Related]
20. Genetic alteration of the alpha2-adrenoceptor subtype c in mice affects the development of behavioral despair and stress-induced increases in plasma corticosterone levels. Sallinen J; Haapalinna A; MacDonald E; Viitamaa T; Lähdesmäki J; Rybnikova E; Pelto-Huikko M; Kobilka BK; Scheinin M Mol Psychiatry; 1999 Sep; 4(5):443-52. PubMed ID: 10523817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]